The increasing price of prescription drugs is an ongoing concern for Medicare and Medicaid, particularly for patients with chronic health conditions who are using multiple medications and patients in these programs taking high-priced brand-name specialty drugs. Shifts in benefit design, including higher deductibles and a movement away from copayments to coinsurance, have increased patient out-of-pocket costs and put pressure on program budgets. In this paper, the American College of Physicians expands on its position paper from 2016 and offers additional recommendations to decrease out-of-pocket costs for patients, enhance the government's purchasing power, and address existing policies that add costs to the health care system.

中文翻译：

---

公共卫生计划的政策建议，以遏制处方药的成本不断上涨：美国医师学院的立场文件。

处方药价格上涨一直是Medicare和Medicaid的关注点，特别是对于正在使用多种药物的慢性健康状况患者以及这些计划中使用高价名牌特种药物的患者。福利设计的转变，包括更高的免赔额以及从共付额向共同保险的转变，增加了患者的自付费用，并给计划预算带来了压力。在本白皮书中，美国内科医师学院从2016年起扩展其立场文件，并提出其他建议，以减少患者的自付费用，增强政府的购买力，并解决增加医疗保健系统成本的现有政策。